<DOC>
	<DOCNO>NCT01144598</DOCNO>
	<brief_summary>The objective measure time delay onset symptom diagnosis time disease-modifying anti-rheumatic drug treatment Turkish patient rheumatoid arthritis . The investigator also evaluate actual work limitation status patient impact demographic clinical factor work limitation rheumatoid arthritis patient .</brief_summary>
	<brief_title>Time DMARD ( Disease-Modifying Anti-Rheumatic Drug ) Treatment Actual Work Limitation Patients With Rheumatoid Arthritis Turkey</brief_title>
	<detailed_description>This post marketing observational study conduct cross-sectional , non-interventional , multi-center format Turkey . As post marketing observational study , Abbott involve product supply since drug use accord approved marketing label prescribe physician usual customary practice physician prescription . Subjects recruit rheumatology outpatient clinic university hospital and/or private office . Patients diagnose rheumatoid arthritis receive least one disease-modifying anti-rheumatic drug , already employ pay work able provide disease history data include . Patient data collect single visit . During single visit , require demographic clinical data record case report form investigator every subject ask fill Work Productivity Activity Impairment questionnaire Health Assessment Questionnaire - Disability Index .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Diagnosed rheumatoid arthritis specialist treat rheumatologist Treated least one diseasemodifying antirheumatic drug biologics Patients 18 year Patients already employ pay work Patients able provide data disease history Able provide write consent release information study Patients provide necessary outcome measurement reason exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Disease-Modifying Anti-Rheumatic Drug</keyword>
	<keyword>Work Limitation</keyword>
</DOC>